logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • In 2024, 17 new stem cell products in my country will be approved for clinical INDs, 14 of which are mesenchymal stem cells!
    2024-07-03
  • People's Daily supports "cell intelligence"! Stem cell therapy will accelerate to benefit all people
    2024-07-02
  • The era of cell therapy is approaching, and induced pluripotent stem cells (iPSC) may be the optimal solution!
    2024-07-01
  • In the first half of the year, 54 cell therapy companies achieved IND progress!
    2024-06-28
  • Inducing pluripotent Stem cells: the key to the era of Personalized Medicine
    2024-06-26
Prev
... 27 28 29 30 31 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号